SCHEMBL640341

SCHEMBL640341

O=C1C=CCON1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL3410123 0.97
SCHEMBL2765250 0.67
Furan-2(5H)-One SCHEMBL25302 0.57
SCHEMBL89327 0.57
SCHEMBL7199064 0.57 GSK3A (0.59)
SCHEMBL2140005 0.56
SCHEMBL2963 0.56
SCHEMBL295203 0.56
Furan-2(5H)-One SCHEMBL28520105 0.56
Methane SCHEMBL595114 0.56

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 427 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3837263-B1 NEW HETEROCYCLIC COMPOUNDS AS MONOACYLGLYCEROL LIPASE INHIBITORS HOFFMANN LA ROCHE (CH) 2024-07-03 EP claimed
CN-113330001-B 3, 3-Difluoroallylamine or salt thereof and pharmaceutical composition comprising the same 柳韩洋行 2024-07-02 CN claimed
CN-118084815-A Synthesis method of 7-bromo-6-chloro-3, 4-dihydro-2H-1, 4-benzoxazine 南通大学 2024-05-28 CN claimed
CN-117999261-A Novel compounds and their use in the treatment of bacterial infections 豪夫迈·罗氏有限公司 2024-05-07 CN claimed
CN-111886233-B Triazolone derivatives or salts thereof and pharmaceutical compositions containing the same 柳韩洋行 2024-01-02 CN claimed
CN-111886227-B Novel aryl or heteroaryl triazolone derivatives or salts thereof, or pharmaceutical compositions containing them 柳韩洋行 2023-10-13 CN claimed
CN-115298176-A Compounds and their use in the treatment of bacterial infections 豪夫迈·罗氏有限公司 2022-11-04 CN claimed
EP-4034239-A1 HETEROCYCLIC COMPOUNDS F. Hoffmann-La Roche AG (CH) 2022-08-03 EP claimed
EP-4028401-A1 4,4A,5,7,8,8A-HEXAPYRIDO[4,3-B][1,4]OXAZIN-3-ONE COMPOUNDS AS MAGL INHIBITORS F. Hoffmann-La Roche AG (CH) 2022-07-20 EP claimed
CN-114650994-A Radiolabelled compounds 豪夫迈·罗氏有限公司 2022-06-21 CN claimed
WO-2004041792-A1 SUBSTITUTED BENZOXAZINONES AND USES THEREOF F. HOFFMANN-LA ROCHE AG (CH) 2004-05-21 WO claimed
EP-1359908-A1 QUINOLINES AND NITROGENATED DERIVATIVES THEREOF SUBSTITUTED IN 4-POSITION BY A PIPERIDINE-CONTAINING MOIETY AND THEIR USE AS ANTIBACTERIAL AGENTS SMITHKLINE BEECHAM PLC (GB) 2003-11-12 EP claimed
WO-2003064421-A1 AMINOPIPERIDINE DERIVATIVES GLAXO GROUP LIMITED (GB) 2003-08-07 WO claimed
WO-2002056882-A1 QUINOLINES AND NITROGENATED DERIVAIVE THEREOF SUBSTITUTED IN 4-POSITION BY A PIPERIDINE-CONTAINING MOIETY AND THEIR USE AS ANTIBACTERIAL AGENTS SMITHKLINE BEECHAM P.L.C. (GB) 2002-07-25 WO claimed
EP-1068191-A1 BENZOXAZINONES/BENZOTHIAZINONES AS SERINE PROTEASE INHIBITORS WARNER-LAMBERT COMPANY LLC (US) 2001-01-17 EP claimed
WO-1999050257-A1 BENZOXAZINONES/BENZOTHIAZINONES AS SERINE PROTEASE INHIBITORS WARNER-LAMBERT COMPANY (US) 1999-10-07 WO claimed
EP-0906294-A1 BENZOXAZINONE DOPAMINE D4 RECEPTOR ANTAGONISTS WARNER-LAMBERT COMPANY (US) 1999-04-07 EP claimed
WO-1997045419-A1 BENZOXAZINONE DOPAMINE D4 RECEPTOR ANTAGONISTS WARNER-LAMBERT COMPANY (US) 1997-12-04 WO claimed
EP-0060330-B1 PROCESS FOR THE PREPARATION OF ORIENTATION LAYERS FOR LIQUID-CRYSTAL DISPLAYS, AND DISPLAYS CONTAINING THESE ORIENTATION LAYERS SIEMENS AKTIENGESELLSCHAFT (DE) 1985-02-13 EP claimed
EP-0024593-B1 PROCESS FOR MAKING AN OPTICAL WAVEGUIDE WITH HIGH TENSILE STRENGTH SIEMENS AKTIENGESELLSCHAFT (DE) 1984-03-21 EP claimed